From a molecular laboratory viewpoint, Relafen 750 (Naproxen) exhibits distinct behaviors. It works primarily as a non-copyrightal drug , preferentially inhibiting cyclooxygenase-2 (COX-2), an enzyme involved in prostaglandin formation. This specific inhibition results in decreased inflammation and discomfort , providing clinical benefits for indiv